Extramural venous invasion is a potential imaging predictive biomarker of neoadjuvant treatment in rectal cancer

Abstract

Patients in whom there has been a significant response of EMVI to CRT show improved DFS. Those patients with poor response should be considered for intensive treatment. As an imaging biomarker in rectal cancer, mrEMVI can be used.